
NGEN
NA
$3.97
$0.00(0.00%)
70
Overall
--
Value
70
Tech
--
Quality
Market Cap
$274.59M
Volume
714.11K
52W Range
$3.51 - $6.30
Target Price
$7.38
Company Overview
| Mkt Cap | $274.59M | Price | $3.97 |
| Volume | 714.11K | Change | +0.00% |
| P/E Ratio | -- | Open | $4.50 |
| Revenue | -- | Prev Close | $3.97 |
| Net Income | -- | 52W Range | $3.51 - $6.30 |
| Div Yield | N/A | Target | $7.38 |
| Overall | 70 | Value | -- |
| Quality | -- | Technical | 70 |
No chart data available
Latest News
NervGen Wins FDA Alignment for Phase 3 RESTORE Trial in Chronic Tetraplegia
TipRanks Canadian Auto-Generated Newsdesk•a day ago
Analysts Offer Insights on Healthcare Companies: Milestone Scientific (MLSS) and NervGen Pharma (NGEN)
Howard Kim•6 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NGEN | $3.97 | 0% | 714.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |